Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Colorectal Cancer
100%
Response to Chemotherapy
100%
Anticancer Immune Response
100%
Insulin-like Growth Factor 2 mRNA-binding Protein 2 (IGF2BP2)
100%
Tumor Microenvironment
64%
Chemotherapy
32%
Tumor Growth
32%
Pro-tumorigenic
21%
Antitumor Effect
21%
Malignant Cells
21%
Tumor Metastasis
21%
Colorectal Tumor
14%
Tumor
14%
Cancer Cells
10%
Colorectal Cancer Cells
10%
Cancer Chemotherapy
10%
Immune Cells
10%
Intestinal Tumor
10%
E3 Ubiquitin Ligase
10%
Colorectal Cancer Patients
10%
Highly Selective
10%
Sensitivity to Chemotherapy
10%
Colorectal Adenocarcinoma Cells
10%
Colon Adenocarcinoma
10%
Liver Metastasis
10%
Antitumor Therapy
10%
Intestinal Epithelial Cells
10%
Metastasis
10%
Phenotypic Modulation
10%
Vulnerability
10%
Poor Response
10%
Immune System
10%
In Cancer
10%
Selective Inhibitor
10%
Anti-tumor Immune
10%
Tumor-immune System
10%
Standard-of-care Chemotherapies
10%
Orthotopic Tumor
10%
Molecular Approaches
10%
Tumor Phenotype
10%
Pharmacologic Approach
10%
Specific Aims
10%
Colorectal Cancer Prevention
10%
Genetic Approach
10%
Chemotherapy Regimen
10%
Pharmacology, Toxicology and Pharmaceutical Science
Colorectal Carcinoma
100%
Chemotherapy Regimens
100%
Tumor Microenvironment
71%
Neoplasm
57%
Tumor Growth
47%
Colon Adenocarcinoma
28%
Malignant Neoplasm
28%
Colorectal Tumor
19%
Intestine Tumor
14%
Ubiquitin Protein Ligase E3
14%
Cancer Chemotherapy
14%
Liver Metastasis
14%
Messenger RNA
14%
Pathogenesis
14%
Biochemistry, Genetics and Molecular Biology
Tumor Progression
100%
Colon
61%
Cancer Cell
61%
Molecular Genetics
30%
Immunocompetent Cell
30%
Anticancer
30%
Genetics
30%
Messenger RNA
30%
Ubiquitin-Conjugating Enzyme
30%
Upregulation
30%